A Historic Milestone: Magellan Biologics & Consulting Enters a New Era with ARCHIMED
Magellan Biologics and its sister company ExcellGene have entered a new strategic partnership with ARCHIMED, a global med-tech investment firm Press Release ARCHIMED acquires cell line development pioneer ExcellGene to accelerate expansion into biosimilars and high-performance transfection solutions September 25, 2025 Global private equity healthcare specialist ARCHIMED acquires a majority stake in family-owned ExcellGene and […]